Researchers devise a progression risk-based classification for patients with AWM
By analyzing data from hundreds of patients with asymptomatic Waldenström macroglobulinemia (AWM), researchers at Dana-Farber Cancer Institute have devised a risk model for determining whether patients with AWM have a low, ...
Apr 23, 2019
0
0